
Citius Pharmaceuticals CTXR
€ 0.61
1.85%
Quartalsbericht 2026-Q2
hinzugefügt 15.05.2026
Citius Pharmaceuticals P/E 2011-2026 | CTXR
P/E Jährlich Citius Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.214 | -0.614 | -0.143 | -4.86 | -4.71 | -2.19 | -0.713 | -1.26 | -1.69 | -4.19 | -13.9 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.143 | -13.9 | -3.14 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-2.15 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.183 | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
5.53 | - | -10.17 % | $ 12.2 K | ||
|
Coherus BioSciences
CHRS
|
1.35 | $ 1.69 | 2.74 % | $ 198 M | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Celldex Therapeutics
CLDX
|
-7.88 | $ 31.72 | 2.82 % | $ 2.11 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | ||
|
BioNTech SE
BNTX
|
-19.4 | $ 93.62 | 1.49 % | $ 22.6 B | ||
|
AstraZeneca PLC
AZN
|
16.3 | - | - | $ 96.9 B | ||
|
CRISPR Therapeutics AG
CRSP
|
-7.54 | $ 53.82 | 4.33 % | $ 4.84 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-0.0167 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
-18.5 | - | 0.74 % | $ 768 M | ||
|
Compugen Ltd.
CGEN
|
5.55 | $ 2.76 | 3.96 % | $ 258 M | ||
|
Abcam plc
ABCM
|
-581 | - | - | $ 4.9 B | ||
|
Galera Therapeutics
GRTX
|
-0.403 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-251 | - | -18.52 % | $ 27.3 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
0.0355 | $ 0.75 | 9.65 % | $ 34.3 M | ||
|
Esperion Therapeutics
ESPR
|
-24.7 | $ 3.13 | 0.16 % | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
-121 | $ 31.98 | 2.21 % | $ 861 M | ||
|
Affimed N.V.
AFMD
|
-9.16 | - | -34.95 % | $ 21.5 M | ||
|
Forte Biosciences
FBRX
|
-4.83 | $ 21.97 | 0.14 % | $ 284 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.859 | - | - | $ 231 M | ||
|
Celyad Oncology SA
CYAD
|
-0.259 | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
-1.19 | - | -7.31 % | $ 87 M | ||
|
Galectin Therapeutics
GALT
|
-5.78 | $ 2.72 | -2.69 % | $ 174 M | ||
|
Generation Bio Co.
GBIO
|
-1.41 | - | - | $ 344 M | ||
|
IMV
IMV
|
-0.18 | - | - | $ 13.1 M | ||
|
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-2.12 | - | 0.23 % | $ 488 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
Grifols, S.A.
GRFS
|
21.2 | $ 8.02 | 0.06 % | $ 5.45 B | ||
|
Hutchison China MediTech Limited
HCM
|
26.3 | $ 11.78 | 0.26 % | $ 10.1 B | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
0.00975 | - | -4.36 % | $ 27 M | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
-2.93 | - | - | $ 384 M | ||
|
Heron Therapeutics
HRTX
|
-9.92 | $ 0.9 | 1.45 % | $ 150 M | ||
|
Gracell Biotechnologies
GRCL
|
-4.4 | - | - | $ 3.37 B | ||
|
ImmuCell Corporation
ICCC
|
-55.8 | $ 10.62 | 1.1 % | $ 95.9 M | ||
|
Anika Therapeutics
ANIK
|
-19.7 | $ 14.67 | -1.48 % | $ 210 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-0.964 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-8.58 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.735 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.489 | $ 3.35 | -2.62 % | $ 5.51 M |